Abstract:Background : Metabolic (dysfunction)-associated fatty liver disease is the most common liver disease related to various metabolic disorders. Colorectal adenomas are related to metabolic dysregulation. Despite the proposed association between non-alcoholic fatty liver disease and colorectal adenomas, the influence of metabolic-associated fatty liver disease on colorectal adenomas has yet to be investigated. Our study investigates the relationship between metabolic-associated fatty liver disease and colorectal adenomas and evaluates the predictive value of fatty liver index for colorectal adenomas. Methods : A retrospective cross-sectional study was conducted on 650 inpatients at Qinghai Provincial People's Hospital. All participants underwent colonoscopy, abdominal ultrasound or CT, relevant laboratory tests, and physical examinations to ascertain baseline characteristics and overall health status. Multivariate logistic regression analysis examined the relationship between metabolic-associated fatty liver disease and colorectal adenomas. Lastly, the ability to identify, accuracy, and clinical applicability of predicting colorectal adenomas through fatty liver index were assessed using receiver operating characteristic curve area under the curve, calibration curve, and decision curve analysis. Result : In both the colorectal adenomas and control groups, the prevalence of metabolic-associated fatty liver disease was 62.1% and 35.7%, respectively. Multivariate analysis indicates that metabolic-associated fatty liver disease was independently correlated with an increased risk of colorectal adenomas (OR, 1.565; 95% CI, 1.057-2.319; P < 0.05). Further analysis revealed that the risk of colorectal adenomas increased with an increasing quantity of metabolic components in metabolic-associated fatty liver disease ( P trend < 0.001). The area under the curve of the fatty liver index predictive model was 0.838, with a 95% CI of 0.807-0.869. The calibration curve indicated excellent agreement, and the decision curve analysis revealed a higher net benefit. Conclusion : The risk of colorectal adenomas was associated with metabolic-associated fatty liver disease, and the risk of developing colorectal adenomas increased with the presence of more metabolic-associated fatty liver disease metabolic components. Furthermore, fatty liver index served as a predictive indicator for screening colorectal adenomas.

Relationship Between Colorectal Adenomatous Polyps and Non-alcoholic Fatty Liver Disease in A Physical Check-up Population

Retrospective Study of Risk Factors for Colorectal Adenomas and Non-Adenomatous Polyps

[Association Between Lifestyle-Related Factors and Colorectal Adenoma].

Correlation Between Obesity and Colorectal Adenoma

Relationship between Nonalcoholic Fatty Liver Disease and Abnormality of Glycolipid Metabolism

[The Association Between Body Mass Index and Non-Alcoholic Fatty Liver Disease].

The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease

ASSA13-10-11 Nonalcoholic Fatty Liver Disease is Associated with Subclinical Atherosclerosis

Association Between High-Density Lipoprotein Cholesterol to Apolipoprotein A-I Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study

Association Between Hemoglobin Levels and Colorectal Polyps in Asymptomatic Chinese Adults

Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components

High Prevalence of Colorectal Neoplasm in Patients with Non-Alcoholic Steatohepatitis

The Fatty Liver Index: A Simple and Accurate Predictor of Colorectal Adenoma in an Average-Risk Population

Transient elastography with controlled attenuation parameter for the diagnosis of colorectal polyps in patients with nonalcoholic fatty liver disease

Predictors for Colorectal Polyps in an Asymptomatic Population Undergoing Medical Check-ups

Study on the Relationship between Phospholipids and Nonalcoholic Fatty Liver Disease

Association Between Non-Alcoholic Fatty Liver Disease and the Risk of Pulmonary Nodules in Patients with Intestinal Polyps

Increased detection rates of advanced colorectal adenoma in women with metabolic dysfunction-associated fatty liver disease

Relationship Between Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.

[Characteristic Analysis of Plasma Lipid Metabolism Level in Patients with Colorectal Adenoma].

High Incidence of Non-Alcoholic Fatty Liver Disease in Patients with Crohn's Disease but Not Ulcerative Colitis